0001209191-23-059791.txt : 20231227 0001209191-23-059791.hdr.sgml : 20231227 20231227163514 ACCESSION NUMBER: 0001209191-23-059791 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231222 FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PICKERING GRANT CENTRAL INDEX KEY: 0001258693 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 231518369 MAIL ADDRESS: STREET 1: C/O VAXCYTE, INC. STREET 2: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD, STE. 300 CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-12-22 0 0001649094 Vaxcyte, Inc. PCVX 0001258693 PICKERING GRANT C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 1 1 0 0 Chief Executive Officer 1 Common Stock 2023-12-22 4 M 0 9900 2.03 A 380814 D Common Stock 2023-12-26 4 M 0 10000 0.04 A 390814 D Common Stock 2023-12-26 4 S 0 7450 61.323 D 383364 D Common Stock 2023-12-26 4 S 0 7550 62.077 D 375814 D Common Stock 152594 I By Children's Trust Common Stock 152594 I By Children's Trust Stock Option (right to buy) 2.03 2023-12-22 4 M 0 9900 0.00 D 2028-07-23 Common Stock 9900 292327 D Stock Option (right to buy) 0.04 2023-12-26 4 M 0 10000 0.00 D 2025-04-23 Common Stock 10000 3663 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.885 to $61.76. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.96 to $62.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Shares are held directly by a trust for the benefit of the Reporting Person's daughter. Shares are held directly by a trust for the benefit of the Reporting Person's son. Stock Option is fully vested and exercisable. Grant Pickering, by /s/ Ron A. Metzger, Attorney-in-Fact 2023-12-27